Catalog No.
RHJ81302
Species reactivity
Human
Host species
Human
Isotype
IgG1, kappa
Clonality
Monoclonal
Applications
ELISA
Target
Linear IgA disease antigen 1, COL17A1, 180 kDa bullous pemphigoid antigen 2, LAD-1, Linear IgA bullous disease antigen of 97 kDa, 120 kDa linear IgA dermatosis antigen, 97-LAD, Collagen alpha-1(XVII) chain, Bullous pemphigoid antigen 2, 97 kDa linear IgA bullous dermatosis antigen, LABD97, 97 kDa LAD antigen, BPAG2, BP180
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q9UMD9
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAb2253
Note
For research use only.
Occurrence of Bullous Pemphigoid in a Longstanding Case of Rheumatoid Arthritis in an Indian Patient: A Rare Association., PMID:38807846
State-of-the-art diagnosis of autoimmune blistering diseases., PMID:38903493
Pemphigus vegetans with autoantibodies against desmocollin and BP180., PMID:38907556
Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease., PMID:38946225
Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort study., PMID:38953405
Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease., PMID:39009587
Serum Biomarkers in Bullous Pemphigoid: A Systematic Review., PMID:39075716
Diagnostic challenge: Juvenile bullous pemphigoid with a negative BP180 ELISA., PMID:39168501
Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases., PMID:39226901
Isolation and analysis of the exosomal membrane proteins in bullous pemphigoid., PMID:39230197
The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific Autoantigen., PMID:39241171
Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity., PMID:39255051
The possible and intriguing relationship between bullous pemphigoid and melanoma: speculations on significance and clinical relevance., PMID:39267741
Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-Analysis., PMID:39356527
Serum inflammatory biomarkers associated with disease severity and response to dupilumab treatment in bullous pemphigoid: A cluster analysis., PMID:39358056
A Case of Acquired Factor V Inhibitor During Bullous Pemphigoid Treatment., PMID:39391459
Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)., PMID:39425892
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid., PMID:39428667
Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study., PMID:39442884
Clinical manifestation variability of bullous pemphigoid., PMID:39487837
Eosinophil extracellular traps drive T follicular helper cell differentiation via VIRMA-dependent MAF stabilization in bullous pemphigoid., PMID:39490750
The "entanglement" between bullous pemphigoid and diabetes mellitus: a comprehensive review and expert recommendations., PMID:39521622
Ocular Mucous Membrane Pemphigoid Demonstrates a Distinct Autoantibody Profile from Those of Other Autoimmune Blistering Diseases: A Preliminary Study., PMID:39584991
Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid., PMID:39592443
Use of multivariant enzyme-linked immunosorbent assay (ELISA) in the diagnosis of autoimmune bullous disorders in a resource-limited setting: A single-center experience., PMID:39635793
Resolution of Bullous Pemphigoid Following Lung Cancer Resection: A Case of Paraneoplastic Pemphigoid., PMID:39669836
Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230., PMID:39676877
Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid., PMID:39694724
Direct Immunofluorescence in Oral Lichen Planus and Related Lesions: Sensitivity, Specificity, and Diagnostic Accuracy in a Single Diagnostic Center in Poland., PMID:39727453
Improvement of immunological tests for detecting autoantibodies in patients with lamina lucida-type linear IgA bullous dermatosis., PMID:39732612
Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism., PMID:39821084
Linear IgA bullous dermatosis-a fifty year experience of Warsaw Center of bullous diseases., PMID:39877369
From Pruritus to Bullae: Recognizing Furosemide-Induced Bullous Pemphigoid in an Elderly Male Patient., PMID:39897249
Correlation of BP180, BP230, and type VII collagen antibody titers in serum, blister fluid, erosion, and saliva in pemphigoid diseases., PMID:39916594
Diagnostic methods and strategies for autoimmune bullous diseases., PMID:39930606
Research in practice: Immune checkpoint inhibitor related autoimmune bullous dermatosis., PMID:39945070
Bullous pemphigoid., PMID:39979318
Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity., PMID:39989295
Localization of Lesions in Autoimmune Blistering Diseases Is Independent of Site-Specific Target Antigen Expression., PMID:40003627
Clinical Outcomes and Prognostic Factors in Bullous Pemphigoid Patients: A 15-Year Review in China., PMID:40059256
[A Case of Bullous Pemphigoid after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma]., PMID:40073898
Epitope Spreading in Immune Checkpoint Inhibitor-Associated Bullous Pemphigoid., PMID:40202746
Unraveling the Link Between Bullous Pemphigoid and Neurological Disease: A Single-center Study of 257 Patients., PMID:40204134
A Case of DPP-4 Inhibitor-Associated Bullous Pemphigoid With Anti-LAD-1 IgG Antibodies Arising From a Post-Traumatic Scar., PMID:40260775
Dupilumab in the Treatment of Pemphigoid Gestationis., PMID:40315477
BAFF modulates T follicular helper cell differentiation through the BAFFR-PI3K/AKT-mTOR signaling pathway in bullous pemphigoid., PMID:40328590
Autoantibody detection by conventional and novel mosaic BIOCHIP technique: A comparative analysis for the diagnosis of autoimmune bullous diseases., PMID:40357957
Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid., PMID:40377009
Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid., PMID:40491922
[Not Available]., PMID:40532789
For research use only. Not for human or drug use.
